Targeting multiple-myeloma-induced immune dysfunction to improve immunotherapy outcomes.

Clinical & Developmental Immunology
Sergio Rutella, Franco Locatelli

Abstract

Multiple myeloma (MM) is a plasma cell malignancy associated with high levels of monoclonal (M) protein in the blood and/or serum. MM can occur de novo or evolve from benign monoclonal gammopathy of undetermined significance (MGUS). Current translational research into MM focuses on the development of combination therapies directed against molecularly defined targets and that are aimed at achieving durable clinical responses. MM cells have a unique ability to evade immunosurveillance through several mechanisms including, among others, expansion of regulatory T cells (Treg), reduced T-cell cytotoxic activity and responsiveness to IL-2, defects in B-cell immunity, and induction of dendritic cell (DC) dysfunction. Immune defects could be a major cause of failure of the recent immunotherapy trials in MM. This article summarizes our current knowledge on the molecular determinants of immune evasion in patients with MM and highlights how these pathways can be targeted to improve patients' clinical outcome.

References

Dec 29, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·A LisoR Levy
Jun 8, 2001·The Journal of Clinical Investigation·T KuroiwaT Iwasaki
Sep 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Yoshiko IwaiNagahiro Minato
Nov 20, 2002·British Journal of Haematology·Carina SeidelUNKNOWN Nordic Myeloma Study Group
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·F Stephen HodiGlenn Dranoff
Jan 11, 2005·British Journal of Haematology·Niels Frost AndersenNiels Abildgaard
May 10, 2005·Transplantation·Reginald M GorczynskiIvo Boudakov
Jun 18, 2005·Genome Biology·Mary CollinsBeatriz M Carreno
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hideto TamuraKiyoyuki Ogata
Sep 10, 2005·Blood·Rao H PrabhalaNikhil C Munshi
Sep 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katsuhide OkunishiKazuhiko Yamamoto
Nov 26, 2005·The Journal of Clinical Investigation·Jens DannullJohannes Vieweg
Feb 21, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·K Jin KimJohn Laterra
May 11, 2006·Blood·Sergio RutellaGiuseppe Leone
Sep 2, 2006·Blood·Jerome MoreauxBernard Klein
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tobias MartensKatrin Lamszus
Mar 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lotta HanssonHåkan Mellstedt
Mar 29, 2007·The Journal of Experimental Medicine·Radek SpisekMadhav V Dhodapkar
May 4, 2007·The Journal of Clinical Investigation·David H Munn, Andrew L Mellor
Jul 25, 2007·Nature Reviews. Cancer·Teru HideshimaKenneth C Anderson
Dec 12, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shuhong HanLung-Ji Chang
May 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raanan BergerArnon Nagler
May 31, 2008·Nature Reviews. Drug Discovery·Paolo M ComoglioLivio Trusolino
Jul 5, 2008·Experimental Hematology·Amorette BarberCharles L Sentman

❮ Previous
Next ❯

Citations

Jul 15, 2015·Critical Reviews in Oncology/hematology·Ayed O AyedJan S Moreb
Sep 10, 2014·International Journal of Cancer. Journal International Du Cancer·Lei WangMichael Schmitt
Dec 12, 2013·Oncoimmunology·Sébastien VielThierry Walzer
Dec 30, 2014·Frontiers in Oncology·Kim De VeirmanJo A Van Ginderachter
Jul 2, 2016·Clinical Lymphoma, Myeloma & Leukemia·Andinet AlemuMichael A Thompson
Jun 21, 2016·Expert Review of Hematology·Sebastian Grosicki, Agnieszka Barchnicka
Dec 4, 2015·Iranian Journal of Cancer Prevention·Soudeh Ghafouri-FardAli Esfandiary
Jan 15, 2014·Expert Review of Hematology·Jacalyn RosenblattDavid E Avigan
Dec 18, 2018·American Journal of Clinical Oncology·Hind RafeiImad A Tabbara
Sep 5, 2015·Current Hematologic Malignancy Reports·Rebecca Karp LeafDavid Avigan
Sep 30, 2017·Journal of Immunotherapy·Rebecca Karp LeafDavid Avigan
Sep 3, 2020·Future Oncology·Semira SheikhSuzanne Trudel
Nov 1, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paola NeriSagar Lonial
Jan 23, 2021·Future Oncology·Sebastian GrosickiOlga Grosicka

❮ Previous
Next ❯

Methods Mentioned

BETA
ISS
xenografts

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.